Skip to main content

Currently Skimming:

Appendix C-Immunosuppression in Allotransplantation
Pages 123-126

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 123...
... These medications attenuate or abolish the immune reactions responsible for rejection. The new generation of immunosuppressive drugs has significantly prolonged graft survival of kidneys, livers, hearts, and heart-lungs, among others.
From page 124...
... The first available anticytokine was cyclosporine, which has twice the effectiveness of azathioprine in extending kidney allograft survival. Cyclosporine inhibits Tcells from producing cytokines, such as interleukin-2, which are the intercellular signals that lead to stimulation of other immune cells to attack the graft.
From page 125...
... All antibody medications derived from animal cell lines have the potential to elicit host sensitization because of foreign epitopes. Recent advances in molecular biology have enabled scientists to "humanize" animal antibodies that could result in no, or .
From page 126...
... These goals underlie research on the identification of new, less toxic immunosuppressives.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.